Interestingly, patients with CRC showed a steeper slope of the regression line between KRAS copy numbers and cfDNA concentrations than healthy individuals (P = 0.0024), whereas the difference between controls and patients with PDA was not significant (P = 0.3552) (Fig. 1B). Here, KRAS is linked to colorectal carcinoma.